Nome Químico: (S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide
Sorrisos: O=C(NC)C1=CC=CC=C1C(NC[C@H]2CN(C3=CC=C(N4C(COCC4)=O)C=C3)C(O2)=O)=O
Inchi: InChI=1S/C18H14N2O4/c21-16-14-8-4-5-9-15(14)17(22)20(16)11-13-10-19(18(23)24-13)12-6-2-1-3-7-12/h1-9,13H,10-11H2/t13-/m1/s1
Development and validation of stability indicating UPLC method for the determination of Rivaroxaban in bulk and finished products and identification of degradation products by LCMS
By Ali, Syed Mastan; Ramachandran, D.
From Journal of Applicable Chemistry (Lumami, India) (2021), 10(3), 291-301
Validated LC-MS/MS method for the determination of three genotoxic impurities in rivaroxaban drug substance
By Korlakunta, Vijaya Gouri; Dasari, Vijaya Bharathi; Sharma, Hemant Kumar; Nowduri, Annapurna; Bonige, Kishore Babu; Chavakula, Ramadas
From European Journal of Biomedical and Pharmaceutical Sciences (2020), 7(8), 492-500
Development of a stability-indicating HPLC method and a dissolution test for rivaroxaban dosage forms
By Souri, Effat; Mottaghi, Siavash; Zargarpoor, Mohammad; Ahmadkhaniha, Reza; Jalalizadeh, Hassan
From Acta Chromatographica (2016), 28(3), 347-361